Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

10.5%

2 terminated/withdrawn out of 19 trials

Success Rate

88.2%

+1.7% vs industry average

Late-Stage Pipeline

63%

12 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

Phase 3

9(47.4%)

N/A

3(15.8%)

Phase 2

3(15.8%)

Phase 4

3(15.8%)

Phase 1

1(5.3%)

19Total

Phase 3(9)

N/A(3)

Phase 2(3)

Phase 4(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials

NCT07562178Not ApplicableNot Yet Recruiting

Pemafibrate for Symptomatic ICAS RCT

Role: collaborator

NCT05923281Phase 3Completed

A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance

Role: lead

NCT04716595Phase 3Completed

A Phase III Long Term Study of K-877 Extended Release Tablet

Role: lead

NCT04079530Phase 2Completed

A Clinical Pharmacology Study of K-877 Controlled Release Tablet

Role: lead

NCT04998981Phase 3Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

Role: lead

NCT04714151Phase 3Completed

A Phase III Confirmatory Study of K-877 Extended Release Tablet

Role: lead

NCT05056883Phase 3Completed

A Phase III Confirmatory Study of K-237

Role: lead

NCT04289649Phase 3Completed

K-924 Phase III Confirmatory Study

Role: lead

NCT04289662Phase 3Completed

K-924 Phase III Long Term Study

Role: lead

NCT05469659Phase 2Recruiting

Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)

Role: collaborator

NCT02649465Phase 4Completed

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

Role: collaborator

NCT03350165Phase 2Completed

A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

Role: lead

NCT01640808Phase 3Completed

Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC

Role: lead

NCT02537834Phase 4Completed

Tofogliflozin GLP-1 Analogue Combination Trial

Role: lead

NCT03345901Phase 3Terminated

PROMINENT-Eye Ancillary Study (Protocol AD)

Role: collaborator

NCT03414294Phase 1Completed

A Study to Evaluate the Safety of K-755 in Healthy Volunteers

Role: lead

NCT02201004Phase 4Completed

TOFO Insulin Combination Trial

Role: collaborator

NCT00548145Not ApplicableTerminated

The Clinical Study of Pitavastatin Treatment for Group of Mild to Moderate Alzheimer's Disease

Role: collaborator

NCT00564902Not ApplicableCompleted

The Zeaxanthin and Visual Function Study

Role: collaborator

All 19 trials loaded